Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bio-rad Laboratories, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.254 Ladies and gentlemen, thank you for standing by. 00:00:02.254 -- 00:00:05.678 My name is Desiree and I will be your conference operator today. 00:00:05.678 -- 00:00:10.685 At this time, I would like to welcome everyone to the BioRad first quarter 2025 earnings 00:00:10.685 -- 00:00:15.791 results conference call and webcast. All lines having place on mute to prevent any background 00:00:15.791 -- 00:00:20.918 noise. After the speaker's remarks, there will be a question and answer session. 00:00:20.918 -- 00:00:24.863 If you would like to ask a question during this time, simply press star followed by the 00:00:24.863 -- 00:00:28.819 number one on your telephone keypad. If you would like to withdraw your question again, 00:00:28.819 -- 00:00:34.084 press the star one. I would now like to turn the conference over to Edward Chung, Head 00:00:34.084 -- 00:00:37.645 of Investor Relations. You may begin. 00:00:37.827 -- 00:00:41.691 Thanks, Desiree. Good afternoon, everyone, and thank you for joining us. 00:00:41.691 -- 00:00:46.495 Today, we will review the first quarter 2025 financial results and provide an update 00:00:46.495 -- 00:00:51.679 on key business trends for BioRad. With me on the call today are Norman Schwartz, 00:00:51.679 -- 00:00:57.592 our Chief Executive Officer, John DiVincenzo, President and Chief Operating Officer, 00:00:57.592 -- 00:01:03.080 and Luke and Rup Lakharaju, Executive Vice President and Chief Financial Officer. 00:01:03.080 -- 00:01:07.667 Before we begin our review, I would like to remind everyone that we'll be making forward-looking 00:01:07.667 -- 00:01:12.954 statements about management's goals, plans and expectations, our future financial performance 00:01:12.954 -- 00:01:17.181 and other matters. T...